Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT HIV Trial
NCT03092817Phase 3Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- May 2017
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in tuberculous meningitis (TBM) comparing Dexamethasone with Identical placebo (2 arms). Primary endpoint: Overall Survival at 12 months. Started May 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT03092817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092817.